Advanced search    

Search: authors:"M. Santoni"

4 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Probing compressed mass spectra in electroweak supersymmetry with Recursive Jigsaw Reconstruction

Jigsaw Reconstruction: HEP event analysis in the presence of kinematic and combinatoric ambiguities, Phys. Rev. D 96 (2017) 112007 [21] P. Jackson, C. Rogan and M. Santoni, Sparticles in motion: Analyzing

Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer

PurposeEvidences have shown that neutrophil-to-lymphocyte ratio (NLR) has a prognostic value in patients with cancer. We wanted to test the prognostic significance of NLR in prostatic cancer of patients who are candidate to radical prostatectomy.MethodsWe have considered 731 patients. Complete demographic data including age, tumor stage, Gleason score, complete blood count and...

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis

Annals of Oncology F. Longo, M. Santoni, F. Morelli, G. Di Lorenzo, A. Altavilla, C. Porta, A. Camerini & B. Escudier on behalf of the Rainbow Group 0 S. Bracarda , R. Iacovelli, L. Boni, M. Rizzo

Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials

Background:About 20% of patients with prostate cancer have an ECOG performance status (PS) 2 at diagnosis. We investigate if current treatment options for castration-resistant prostate cancer (CRPC) may decrease the risk of death even in patients with ECOG PS of 2.Methods:PubMed was reviewed for phase III randomized trials in patients with CRPC progressed after docetaxel...